Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV

Journal of Clinical Investigation

Volumn 115, Issue 4, 2005, Pages 996-1005

  Juang, Yuang Taung ^a,b   Wang, Ying ^a   Solomou, Elena E ^a   Li, Yansong ^a   Mawrin, Christian ^a   Tenbrock, Klaus ^a   Kyttaris, Vasileios C ^a,b,c   Tsokos, George C ^a,b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE (CALCIUM,CALMODULIN) IV; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CREM; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE OVEREXPRESSION; GENE REPRESSION; GENE SYNTHESIS; HUMAN; HUMAN CELL; IL 2 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 16844376445     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI22854     Document Type: Article

References (45)

1. Linker-Israeli, M., et al. 1983. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J. Immunol. 130:2651-2655.
2. Theofilopoulos, A.N., and Dixon, F.J. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37:269-390.
3. Iliopoulos, A.G., and Tsokos, G.C. 1996. Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin. Arthritis Rheum. 25:318-336.
4. Kovacs, B., Vassilopoulos, D., Vogelgesang, S.A., and Tsokos, G.C. 1996. Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: role of decreased intracellular TNF-alpha. Clin. Immunol. Immunopathol. 81:293-302.
5. Solomou, E.E.Juang, Y.T., Gourley, M.F., Kammer, G.M., and Tsokos, G.C. 2001. Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. J. Immunol. 166:4216-4222.
6. Tenbrock, K., Juang, Y.-T., Gourley, M.F., Nambiar, M.P., and Tsokos, G.C. 2002. Antisense cyclic adenosine 5′-monophosphate response element modulator up-regulates IL-2 in T cells from patients with systemic lupus erythematosus. J. Immunol. 169:4147-4152.
7. De Cesare, D., Fimia, G.M., and Sassone-Corsi, P. 1999. Signaling routes to CREM and CREB: plasticity in transcriptional activation. Trends Biochem. Sci. 24:281-285.
8. Lee, K.A., and Masson, N. 1993. Transcriptional regulation by CREB and its relatives. Biochim. Biophys. Acta. 1174:221-233.
9. Powell, J.D., Lerner, C.G., Ewoldt, G.R., and Schwartz, R.H. 1999. The -180 site of the IL-2 promoter is the target of CREB/CREM binding in T cell anergy. J. Immunol. 163:6631-6639.
10. Tada, Y., Nagasawa, K., Yamauchi, Y., Tsukamoto, H., and Niho, Y. 1991. A defect in the protein kinase C system in T cells from patients with systemic lupus erythematosus. Clin. Immunol. Immunopathol. 60:220-231.
11. Cedeno, S., et al. 2003. Defective activity of ERK-1 and ERK-2 mitogen-activated protein kinases in peripheral blood T lymphocytes from patients with systemic lupus eryrhematosus: potential role of altered coupling of Ras guanine nucleotide exchange factor hSos to adapter protein Grb2 in lupus T cells. Clin. Immunol. 106:41-49.
12. Kammer, G.M. 2002. Deficient protein kinase A in systemic lupus erythematosus: a disorder of T lymphocyte signal transduction. Ann. N. Y. Acad. Sci. 968:96-105.
13. Vassilopoulos, D., Kovacs, B., and Tsokos, G.C. 1995. TCR/CD3 complex-mediated signal transduction pathway in T cells and cell lines from patients with systemic lupus erythematosus. J. Immunol. 155:2269-2281.
14. de Groot, R.P., Ballou, L.M., and Sassone-Corsi, P. 1995. Positive regulation of the nuclear activator CREM by the mitogen-induced p70 S6 kinase. Immunobiology. 193:155-160.
15. Krebs, J., Wilson, A., and Kisielow, P. 1997. Calmodulin-dependent protein kinase IV during T-cell development. Biochem. Biophys. Res. Commun. 241:383-389.
16. Blanco, P., Palucka, A.K., Gill, M., Pascual, V., and Banchereau, J. 2001. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science. 294:1540-1543.
17. Winfield, J.B., and Mimura, T. 1992. Pathogenetic significance of anti-lymphocyte autoantibodies in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 63:13-16.
18. Dash, P.K., Karl, K.A., Colicos, M.A., Prywes, R., and Kandel, E.R. 1991. cAMP response element-binding protein is activated by Ca2+/calmodulin- as well as cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. U. S. A. 88:5061-5065.
19. Bito, H., Deisseroth, K., and Tsien, R.W. 1996. CREB phosphorylation and dephosphorylation: a Ca(2+)- and stimulus duration-dependent switch for hippocampal gene expression. Cell. 87:1203-1214.
20. Groussin, L., Massias, J.F., Bertagna, X., and Bertherat, J. 2000. Loss of expression of the ubiquitous transcription factor cAMP response element-binding protein (CREB) and compensatory overexpression of the activator CREMtau in the human adrenocortical cancer cell line H295R. J. Clin. Endocrinol Metab. 85:345-354.
21. Hummler, E., et al. 1994. Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors. Proc. Natl. Acad. Sci. U. S. A. 91:5647-5651.
22. de Groot, R.P., Ballou, L.M., and Sassone-Corsi, P. 1994. Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: an alternative route to mitogen-induced gene expression. Cell. 79:81-91.
23. Jensen, K.F., Ohmstede, C.A., Fisher, R.S.,and Sahyoun, N. 1991. Nuclear and axonal localization of Ca2+/calmodulin-dependentprotein kinase type Gr in rat cerebellar cortex. Proc. Natl Acad. Sci. U. S. A. 88:2850-2853.
24. Hanissian, S.H., Frangakis, M., Bland, M.M.,Jawahar, S., and Chatila, T.A. 1993. Expression of a Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, in human T lymphocytes. Regulation of kinase activity by T cell receptor signaling. J. Biol. Chem. 268:20055-20063.
25. Frangakis, M.V., Chatila, T., Wood, E.R., and Sahyoun, N. 1991. Expression of a neuronal Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, in rat thymus. J. Biol. Chem. 266:17592-17596.
26. Wayman, G.A., Tokumitsu, H., and Soderling, T.R. 1997. Inhibitory cross-talk by cAMP kinase on the calmodulin-dependenf protein kinase cascade. J. Biol. Chem. 272:16073-16076.
27. MacNicol, M., and Schulman, H. 1992. Cross-talk between protein kinase C and multifunctional Ca2+/calmodulin-dependent protein kinase. J. Biol. Chem. 267:12197-12201.
28. Sun, P., Lou, L., and Maurer, R.A. 1996. Regulation of activating transcription factor-1 and the cAMP response element-binding protein by Ca2+/calmodulin-dependent protein kinases type I, II, and IV. J. Biol. Chem. 271:3066-3073.
29. Heist, E.K., Srinivasan, M., and Schulman, H. 1998. Phosphorylation at the nuclear localization signal of Ca2+/calmodulin-dependent protein kinase II blocks its nuclear targeting. J. Biol. Chem. 273:19763-19771.
30. Anderson, K.A., and Kane, C.D. 1998. Ca2+/calmodulin-dependent protein kinase IV and calcium signaling. Biometals. 11:331-343.
31. Selbert, M.A., et al. 1995. Phosphorylation and activation of Ca(2+)-calmodulin-dependent protein kinase IV by Ca(2+)-calmodulin-dependent protein kinase la kinase. Phosphorylation of threonine 196 is essential for activation. J. Biol. Chem. 270:17616-17621.
32. Linker-Israeli, M., et al. 1999. Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression. Genes Immun. 1:45-52.
33. Tenbrock, K., Juang, Y.-T., Tolnay, M., and Tsokos, G.C. 2003. The cyclic adenosine 5′-monophosphate response element modulator suppresses IL-2 production in stimulated T cells by a chromatin-dependent mechanism. J. Immunol. 170:2971-2976.
34. Tsokos, G.C. 1999. Overview of cellular immune function in systemic lupus erythematosus. In Systemic lupus erythematosus. R.G. Lahita, editor. Academic Press. New York, New York, USA. 17-54.
35. Stohl, W. 1999. Impaired non-antigen specific T cell cytolytic activity in SLE. In Lupus: molecular and cellular pathogenesis. G.M. Kammer and G.C. Tsokos, editors. Humana Press Inc. Totowa, New Jersey, USA. 299-311.
36. Malek, T.R., and Bayer, A.L. 2004. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 4:665-674.
37. Koshy, M., Berger, D., and Crow, M.K. 1996. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J. Clin. Invest. 98:826-837.
38. Desai-Mehta, A., Lu, L., Ramsey-Goldman, R., and Datta, S.K. 1996. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 97:2063-2073.
39. Weiss, A., and Stobo, J.D. 1984. Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line. J. Exp. Med. 160:1284-1299.
40. Tolnay, M., Vereshchagina, L.A., and Tsokos, G.C. 1999. Heterogeneous nuclear ribonucleoprotein DOB is a sequence-specific DNA-binding protein. Biochem. J. 338:417-425.
41. Chatila, T., Anderson, K.A., Ho, N., and Means, A.R. 1996. A unique phosphorylation-dependent mechanism for the activation of Ca2+/calmodulin- dependent protein kinase type IV/GR. J. Biol. Chem. 271:21542-21548.
42. Cruzalegui, F.H., and Means, A.R. 1993. Biochemical characterization of the multifunctional Ca2+/calmodulin-dependent protein kinase type IV expressed in insect cells. J. Biol. Chem. 268:26171-26178.
43. Enslen, H., Tokumitsu, H., Stork, P.J., Davis, R.J., and Soderling, T.R. 1996. Regulation of mitogen-activated protein kinases by a calcium/calmodulin- dependent protein kinase cascade. Proc. Natl. Acad. Sci. U. S. A. 93:10803-10808.
44. Nielson, C.P., and Wingett, D. 2002. Endothelial cell and cAMP regulation of T-cell CD40 ligand: relevance of calcium/calmodulin-dependent kinase IV signalling. Immunology. 105:430-440.
45. Solomou, E.E., Juang, Y.T., and Tsokos, G.C. 2001. Protein kinase C-theta participates in the activation of cyclic AMP-responsive element-binding protein and its subsequent binding to the-180 site of the IL-2 promoter in normal human T lymphocytes. J. Immunol. 166:5665-5674.